The Company develops, acquires and commercializes novel treatments for cancer and focuses its research and in-licensing activities on identifying and developing new, less toxic and effective ways to treat cancer.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
I HAVE BEEN FOLLOWING CTIC FOR ABOUT 6 MONTHS NOW...HAVE CASHED OUT ON PROFITS ONCE SO FAR AND WILL AGAIN VERY SOON. TOOK PART IN THE PHONE UPDATE THIS MORNING AND BOUGHT ANOTHER BLOCK OF STOCKS...I'M A STRONG BELIEVER THAT THIS STOCK WILL SOON TAKE OFF.
FDA WILL DECIDE ABOUT FAST TRACK LATER THIS MONTH...SHOULD SEE A JUMP IN STOCK STRENGTH IN THE WEEK LEADING UP TO THE ANNOUNCEMENT THEN ANOTHER JUMP IF CTIC RECEIVES A FAVORABLE DECISSION. DECEMBER 24TH WILL THEN BRING A VERY HAPPY HOLIDAY TO THE SHAREHOLDERS. LET IT BE WRITTEN ...LET IT BE DONE!
Friday August 21...before the bell looks very promising...sold 60 % of holdings on up day @ 1.74 bought position back at 1.66 ...I have a very good attitude about this company ...also just took a strong position in YMI and CRIS and hope to take a position in SPPI today. People you are looking at a once in a life time opportunity here...support this company....